Abstract:BACKGROUND:In an effort to reconstitute the NAD(+) synthetic pathway in Escherichia coli (E. coli), we produced a set of gene knockout mutants with deficiencies in previously well-defined NAD(+)de novo and salvage pathways. Unexpectedly, the mutant deficient in NAD(+) de novo and salvage pathway I could grow in M9/nicotinamide medium, which was contradictory to the proposed classic NAD(+) metabolism of E. coli. Such E. coli mutagenesis assay suggested the presence of an undefined machinery to feed nicotinamide into the NAD(+) biosynthesis. We wanted to verify whether xanthosine phophorylase (xapA) contributed to a new NAD(+) salvage pathway from nicotinamide.RESULTS:Additional knockout of xapA further slowed down the bacterial growth in M9/nicotinamide medium, whereas the complementation of xapA restored the growth phenotype. To further validate the new function of xapA, we cloned and expressed E. coli xapA as a recombinant soluble protein. Biochemical assay confirmed that xapA was capable of using nicotinamide as a substrate for nicotinamide riboside formation.CONCLUSIONS:Both the genetic and biochemical evidences indicated that xapA could convert nicotinamide to nicotinamide riboside in E. coli, albeit with relatively weak activity, indicating that xapA may contribute to a second NAD(+) salvage pathway from nicotinamide. We speculate that this xapA-mediated NAD(+) salvage pathway might be significant in some bacteria lacking NAD(+) de novo and NAD(+) salvage pathway I or II, to not only use nicotinamide riboside, but also nicotinamide as precursors to synthesize NAD(+). However, this speculation needs to be experimentally tested.

Strategy for Efficient Importing and Function Characterizing of Nicotinamide Adenosine Dinucleotide Analogs in Escherichia coli Cells

Systematic Engineering of Escherichia coli for Efficient Production of Nicotinamide Mononucleotide From Nicotinamide

Creating enzymes and self-sufficient cells for biosynthesis of the non-natural cofactor nicotinamide cytosine dinucleotide

Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor

Improving the production of NAD+ via multi-strategy metabolic engineering in Escherichia coli

New Approaches to NAD(P)H Regeneration in the Biosynthesis Systems.

Insight into Role of Nicotinamide Involved in Energy Metabolism and Redox Homeostasis: A Case Study in Strawberry

Construction of an Alternative NAD + De Novo Biosynthesis Pathway

Exploring the De Novo NMN Biosynthesis as an Alternative Pathway to Enhance NMN Production

New Function for Escherichia Coli Xanthosine Phophorylase (xapa): Genetic and Biochemical Evidences on Its Participation in NAD(+) Salvage from Nicotinamide.

Exploring NAD + metabolism and NNAT: Insights from structure, function, and computational modeling

Doped Graphene to Mimic the Bacterial NADH Oxidase for One-Step NAD+ Supplementation in Mammals.

Metabolic Engineering of Bacillus licheniformis for the Bioproduction of Nicotinamide Riboside from Nicotinamide and Glucose

Design and tailoring of an artificial DNA scaffolding system for efficient production of nicotinamide mononucleotide

Illuminating NAD+ Metabolism in Live Cells and in Vivo Using a Genetically Encoded Fluorescent Sensor.

Quantitative dynamics of intracellular NMN by genetically encoded biosensor

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide

Structure-guided mining and engineering of nicotinamide riboside kinase for efficient synthesis of nicotinamide mononucleotide

Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide

Rapid Prototyping Enzyme Homologs to Improve Titer of Nicotinamide Mononucleotide Using a Strategy Combining Cell‐free Protein Synthesis with Split GFP

A Genetically Encoded Redox-Active Nicotinamide Amino Acid